On Friday, I gave you all a recap of our latest biotech event, “Boston’s Life Science Disruptors.” As promised, today I’m circling back with some of the photos. As you’ll see, last week’s Boston monsoon cleared up just in time for the party.
Thanks again to our sponsors—BDO, Boston Children’s Hospital, Johnson & Johnson Innovation, New England Lab, and The Richmond Group—and to our speakers and event host Novartis. And of course a thanks to Keith Spiro of Keith Spiro Photography for all the shots you’ll see here. Catch you all in Boston again next time.
Author: Ben Fidler
Ben is former Xconomy Deputy Editor, Biotechnology. He is a seasoned business journalist that comes to Xconomy after a nine-year stint at The Deal, where he covered corporate transactions in industries ranging from biotech to auto parts and gaming. Most recently, Ben was The Deal’s senior healthcare writer, focusing on acquisitions, venture financings, IPOs, partnerships and industry trends in the pharmaceutical, biotech, diagnostics and med tech spaces. Ben wrote features on creative biotech financing models, analyses of middle market and large cap buyouts, spin-offs and restructurings, and enterprise pieces on legal issues such as pay-for-delay agreements and the Affordable Care Act. Before switching to the healthcare beat, Ben was The Deal's senior bankruptcy reporter, covering the restructurings of the Texas Rangers, Phoenix Coyotes, GM, Delphi, Trump Entertainment Resorts and Blockbuster, among others. Ben has a bachelor’s degree in English from Binghamton University.
View all posts by Ben Fidler
